Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 19, 2010
- Accepted March 16, 2010
- Published online May 14, 2010.
Article Versions
- Earlier version (March 17, 2010 - 06:58).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Robert J. Mourey,
- Barry L. Burnette,
- Sarah J. Brustkern,
- J. Scott Daniels,
- Jeffrey L. Hirsch,
- William F. Hood,
- Marvin J. Meyers,
- Stephen J. Mnich,
- Betsy S. Pierce,
- Matthew J. Saabye,
- John F. Schindler,
- Sarah A. South,
- Elizabeth G. Webb,
- Jian Zhang and
- David R. Anderson
- Departments of Discovery Biology (R.J.M., B.L.B., S.J.B., J.L.H., W.F.H., S.J.M., M.J.S., J.F.S., E.G.W., J.Z.), Medicinal Chemistry (M.J.M., B.S.P., D.R.A.), and Pharmacokinetics, Dynamics, and Metabolism (J.S.D., S.A.S), Inflammation Research Unit, Pfizer Global Research and Development, Chesterfield, Missouri
- Address correspondence to:
David R. Anderson, Chemistry Discovery, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340. E-mail: david.r.anderson{at}pfizer.com
Portions of this work were presented as: Daniels JS, Lai Y, Davis JW, South SA, Stevens JC, Mourey RJ, and Anderson DR (2008) Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to liver toxicity in nonclinical species at Great Lakes Drug Metabolism Discussion Group Meeting; 2008 May 1–2; Indianapolis, IN. Great Lakes Drug Metabolism Discussion Group, University of Michigan, Ann Arbor, MI.